Junto Capital Management LP Takes $46.88 Million Position in Danaher Corporation $DHR

Key Points

• Junto Capital Management LP acquired 228,671 shares of Danaher Corporation, valued at approximately $46.9 million, during the first quarter of the year.
• Institutional investors now own 79.05% of Danaher's stock, indicating strong institutional confidence in the company.
• Danaher reported a quarterly earnings per share of $1.80, surpassing analyst expectations, with revenue of $5.94 billion, a 3.4% increase year-over-year.

Junto Capital Management LP purchased a new stake in Danaher Corporation (NYSE:DHR - Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 228,671 shares of the conglomerate's stock, valued at approximately $46,878,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Coastal Bridge Advisors LLC lifted its holdings in Danaher by 4.8% in the fourth quarter. Coastal Bridge Advisors LLC now owns 1,099 shares of the conglomerate's stock valued at $252,000 after acquiring an additional 50 shares during the period. Hills Bank & Trust Co lifted its holdings in Danaher by 0.3% in the first quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate's stock valued at $3,693,000 after acquiring an additional 53 shares during the period. Sageworth Trust Co lifted its holdings in Danaher by 2.3% in the first quarter. Sageworth Trust Co now owns 2,404 shares of the conglomerate's stock valued at $493,000 after acquiring an additional 54 shares during the period. 1834 Investment Advisors Co. lifted its holdings in Danaher by 3.3% in the first quarter. 1834 Investment Advisors Co. now owns 1,666 shares of the conglomerate's stock valued at $342,000 after acquiring an additional 54 shares during the period. Finally, Rakuten Securities Inc. lifted its holdings in Danaher by 33.3% in the first quarter. Rakuten Securities Inc. now owns 224 shares of the conglomerate's stock valued at $46,000 after acquiring an additional 56 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 2,778 shares of the business's stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 11.10% of the company's stock.

Danaher Stock Down 2.2%

NYSE DHR traded down $4.39 during trading on Wednesday, reaching $199.40. 3,485,231 shares of the company's stock were exchanged, compared to its average volume of 4,157,147. The stock has a market cap of $142.78 billion, a P/E ratio of 42.43, a price-to-earnings-growth ratio of 2.87 and a beta of 0.75. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The company has a 50 day moving average price of $201.97 and a two-hundred day moving average price of $199.49. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same period in the previous year, the business earned $1.72 EPS. The business's quarterly revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft decreased their target price on Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Barclays reiterated an "overweight" rating and set a $225.00 price objective (up previously from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Evercore ISI reduced their price objective on Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. Royal Bank Of Canada set a $241.00 target price on Danaher in a research note on Tuesday. Finally, Robert W. Baird boosted their target price on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research note on Friday, July 18th. Seventeen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $246.35.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.